News

Soren Stroh, founder and previous owner, continues his role as CEO of aCROnordic for Nordic region. aCROnordic is a provider of drug and medical device development services to

The company is constructing a new 60,000sqft building adjacent to existing buildings to create a Slough campus. Lonza‘s Slough site is into developing and manufacturing antibodies and therapeutic

Headquartered in New Jersey, JHP Pharma is a provider of contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations.

The payment triggers from the transferring of Alnylam‘s RNA interference drug technology to Takeda Pharma for the development of RNAi therapeutics. Earlier, Alnylam has obtained $140m in upfront

The Phase 1, open-label, randomised, clinical trial will be conducted at three clinical sites in Northern California, US. The study will enroll 40 postmenopausal women between the ages

The India-based company is close to completing the Phase I clinical trial of NRC-AN-019 in India, and is planning to conduct further clinical trials in the US and

Slimple contains MaCoca, a proprietary blend that is derived from Decocainized Coca Leaf, that burns more calories through a process konown as Thermogenesis. Slimple acts as a fat

Chiltern is a clinical contract research organization (CRO) with experience in the management of Phase I-IV clinical trials across a range of therapeutic areas, functional service provision and

MyKidz Iron products are liquid supplements that help reduce the staining of teeth associated with iron. Three formulations – MyKidz Iron, MyKidz Iron 10 and MyKidz Iron FL